Phillips‑Medisize (a Molex company)
Drug Product
Manufacturing & Lab Equipment
Company Overview
About
Phillips‑Medisize (a Molex company) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:China
Founded:1993
Employees:1,938
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Technology Platforms
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
Global
Manufacturing Facilities
7 sites worldwide
Phillips‑Medisize (a Molex company) - China Facility
China
Site Capabilities
Quality Control
Stability Testing
Method Development
Phillips‑Medisize (a Molex company) - Czechia Facility
Czechia
Site Capabilities
Quality Control
Stability Testing
Method Development
Phillips‑Medisize (a Molex company) - Denmark Facility
Denmark
Site Capabilities
Quality Control
Stability Testing
Method Development
Phillips‑Medisize (a Molex company) - Finland Facility
Finland
Site Capabilities
Quality Control
Stability Testing
Method Development
Phillips‑Medisize (a Molex company) - Ireland Facility
Ireland
Site Capabilities
Quality Control
Stability Testing
Method Development
Phillips‑Medisize (a Molex company) - Mexico Facility
Mexico
Site Capabilities
Quality Control
Stability Testing
Method Development
Phillips‑Medisize (a Molex company) - United States Facility
United States
Site Capabilities
Quality Control
Stability Testing
Method Development
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-A2X4CTLD
Issued: 2020-02-10
Expires: 2025-08-18
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-CT9BVUNW
Issued: 2020-09-23
Expires: 2025-04-19
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-QN0E5NBX
Issued: 2020-10-14
Expires: 2025-09-18
Customer Reviews
No reviews available yet.
Company Documents
No documents available.
Loading CDMO intelligence...